Myelodysplastic syndromes trials in Finland
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Helsinki, Tampere
- Age
- 18 years to 75 years
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - Phase 2Taking peopleBexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Where
- Helsinki, Oulu, Tampere, Turku
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Faron Pharmaceuticals Ltd
See details and how to joinNCT07672769 · EU 2026-526706-33-00 - Phase 3Taking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Helsinki, Kuopio, Tampere
- Age
- 18 years and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - Phase 4Not yet taking people in FinlandAntibiotic Prophylaxis in Hematopoietic Stem Cell Transplantation: a Randomised Controlled Trial - The ANTURA trial
- Where
- Helsinki
- Age
- 18 years to 64 years
- People
- 150
- Run by
- HUS-yhtymae
See details and how to join2025-524982-25-00 · EU 2025-524982-25-00 - Phase 1/2Not yet taking people in FinlandA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Helsinki, Turku
- Age
- 18 years and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - Phase 2Taking peopleNMDSG-14B2
- Where
- Helsinki
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2024-511651-17-00 · EU 2024-511651-17-00